1. An official ATS/IDSA statement: diagnosis, treatment and prevention of nontuberculosis mycobacterial diseases. American Thoracic Society Statement;Griffith;Am J Respir Crit Care Med,2007
2. Brown-Elliot BA, McGlasson M, Painter P, Mann L, Hail D, Battee L, Wallace Jr, RJ et al. Comparison of antimicrobials including besifloxacin, ciprofloxacin, gatifloxacin, moxifloxacin, levofloxacin, azithromycin, clarithromycin, amikacin, imipenem and tobramycin against ophthalmic isolates of nontuberculosis mycobacteria. Abstract U-041. Abstracts of the 109th General Meeting of the American Society for Microbiology, Philadelphia, PA, USA, 2009.
3. Mycobacterium fortuitum: um novo bacilo ácido-resistente patogênico para o homem (New acid-fast bacillus pathogenic for man);da Costa Cruz;Acta Med (Rio de Janeiro),1938
4. Nosocomial outbreaks/pseudo-outbreaks caused by nontuberculous mycobacteria;Wallace;Annu Rev Microbiol,1998
5. Infections due to rapidly growing mycobacteria;De Groote;Clin Infect Dis,2006